PASQUALONE FRANK 4
4 · Theravance Biopharma, Inc. · Filed May 22, 2019
Insider Transaction Report
Form 4
PASQUALONE FRANK
Sr. VP, Operations
Transactions
- Tax Payment
Ordinary Shares
2019-05-20$19.84/sh−1,604$31,823→ 323,094 total
Footnotes (1)
- [F1]Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019.